Cancer Research Institute Study Says Development of Immuno-Oncology Therapies for Cancer Treatment Continue to Grow Globally
October 29, 2019
October 29, 2019
NEW YORK, Oct. 29 -- Cancer Research Institute issued the following news:
NEW YORK and LONDON--The number of immuno-oncology (IO) therapies in clinical development and volume of clinical investigations testing these therapies for the treatment of cancer patients continue to grow, and will undoubtedly fulfill unmet needs in both hematological cancers and solid tumors over the next five to ten years.
Leveraging data from GlobalData's Pharma Intelligence platform, an Immu . . .
NEW YORK and LONDON--The number of immuno-oncology (IO) therapies in clinical development and volume of clinical investigations testing these therapies for the treatment of cancer patients continue to grow, and will undoubtedly fulfill unmet needs in both hematological cancers and solid tumors over the next five to ten years.
Leveraging data from GlobalData's Pharma Intelligence platform, an Immu . . .